|
|
Article: Study Supports Whooping Cough Booster Shot for Adolescents; Analysis Weighs Costs, Efficacy, Disease Severity, Vaccine Side Effects.
- Article from:
- AScribe Medicine News Service
- Article date:
- June 5, 2005
CopyrightCOPYRIGHT 2005 AScribe. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Harvard University Medical School
BOSTON, June 6 (AScribe Newswire) -- Despite childhood vaccination rates at all-time highs, pertussis (whooping cough) has re-emerged over the past two decades, especially among adolescents, adults, and young infants. Because of this resurgence, federal health policymakers are considering a national booster vaccination program. An analysis by Harvard Medical School researchers in the June issue of Pediatrics offers support for the adolescent booster, concluding that one-time vaccination at 11 years of age may potentially be cost-effective.
The Advisory Committee on Immunization Practices, which advises the ...